Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Patients also have to deal with changes to their health insurance at the start of a new year, and more employers have withdrawn coverage of the pricey medications. About half of the people who stop taking GLP-1s, like Eli Lilly's LLY Zepbound or Novo Nordisk's NVO Wegovy, discover that they gain back all the weight they lost within two years. These stocks are the biggest winners as TSMC earnings supercharge the AI trade The ‘risky trinity' is the most underappreciated market threat right now. These are the stock moves to make. Mortgage rates fall to lowest level in over 3 years as home-buying activity picks up Here's how much money you need to make to afford a $400,000 home “The only way that they work is if you keep taking them,” said Scott Isaacs, an endocrinologist at the Grady Health System in Atlanta. “And when people stop taking them, they have a lot of weight regain, and the medical problems that went away tend to come back.” There's a group of patients who are now
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- This Company Is Doubling Down on AI. Is the Stock a Buy? [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid' launch [CNBC]CNBC
- Eli Lilly: Exceptional 2025, But Rising Headwinds Loom In 2026 [Seeking Alpha]Seeking Alpha
- JPM26: Eli Lilly's obesity drugs target commercial and governmental access [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at Jefferies Financial Group Inc. from $976.00 to $1,300.00. They now have a "buy" rating on the stock.MarketBeat
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 1/8/26 - Form 4
- 1/6/26 - Form 3
- 1/6/26 - Form 4
- LLY's page on the SEC website